Pipeline Embolization for Intracranial Aneurysms

NCT06446778 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-11-18

No results posted yet for this study

Summary

This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.

Conditions

  • Efficacy, Self
  • Hemodynamic Instability
  • Stenosis
  • Aneurysm, Intracranial

Interventions

DEVICE

Pipeline embolization device with or without shield technique

The patients undenwent Pipeline embolization device implantation with or without shield technique due to market availability, choice and preferences of the surgeon.

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Eighth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Zhongshan Hospital Of Traditional Chinese Medicine

    collaborator OTHER
  • First Affiliated Hospital of Jinan University

    collaborator OTHER
  • Beijing Tiantan Hospital

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Affiliated Hospital of Southwest Medical University

    collaborator OTHER
  • Guangdong 999 Brain Hospital

    collaborator OTHER
  • Shantou Central Hospital

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Chuanzhi Duan, MD · Zhujiang Hospital

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2027-09-01
Completion
2030-09-01
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06446778 on ClinicalTrials.gov